Planet 13 Holdings (PLNH) Shares Outstanding (Weighted Average) (2020 - 2026)

Planet 13 Holdings (PLNH) reported Shares Outstanding (Weighted Average) of $327.9 million for Q1 2026, up 0.82% year-over-year from $325.3 million in Q1 2025, and up 1648.92% quarter-over-quarter from $18.8 million in Q4 2025.

Planet 13 Holdings (PLNH) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has 7 years of Shares Outstanding (Weighted Average) data on file, last reported at $327.9 million in Q1 2026.

  • Shares Outstanding (Weighted Average) for Q1 2026 came in at $327.9 million, up 0.82% year-over-year; the trailing twelve-month figure through Mar 2026 was $327.9 million (up 0.82% YoY), and the FY2025 annual result was $325.3 million, up 11.35% from the prior year.
  • Shares Outstanding (Weighted Average) rose to $327.9 million in Q1 2026 per PLNH's latest filing, from $18.8 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $327.9 million in Q1 2026 and troughed at $5.2 million in Q4 2022.
  • A 5-year average of $215.4 million and a median of $225.1 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
  • The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) slumped 41.25% in 2022, then surged 42.39% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $5.2 million in 2022, then soared by 4158.4% to $221.7 million in 2023, then slumped by 91.54% to $18.8 million in 2024, then changed by 0.0% to $18.8 million in 2025, then surged by 1648.92% to $327.9 million in 2026.
  • Business Quant data shows PLNH's Shares Outstanding (Weighted Average) at $327.9 million in Q1 2026, $18.8 million in Q4 2025, and $325.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Weighted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 39.97 Bn 36.23 Bn 1.97 Bn 1.16 Bn
2 Zoetis 33.59 Bn 31.65 Bn 1.62 Bn 422.10 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 43.50 Mn
4 Neurocrine Biosciences 16.10 Bn 14.78 Bn 800.70 Mn 100.50 Mn
5 Aurora Cannabis 15.56 Bn 15.47 Bn 21.72 Mn 5.11 Bn
6 Elanco Animal Health 12.04 Bn 11.61 Bn 785.00 Mn 497.70 Mn
7 Alkermes 7.36 Bn 6.84 Bn -116.06 Mn 166.20 Mn
8 Lantheus Holdings 6.74 Bn 6.24 Bn 230.92 Mn 64.74 Mn
9 Liquidia 6.27 Bn 6.04 Bn 121.79 Mn 88.01 Mn
10 Planet 13 Holdings - - 9.41 Mn 327.92 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 327.92 Mn
Dec 31, 2025 18.75 Mn
Sep 30, 2025 325.36 Mn
Jun 30, 2025 325.31 Mn
Mar 31, 2025 325.26 Mn
Dec 31, 2024 18.75 Mn
Sep 30, 2024 281.09 Mn
Jun 30, 2024 289.18 Mn
Mar 31, 2024 228.44 Mn
Sep 30, 2023 221.71 Mn
Jun 30, 2023 221.44 Mn
Mar 31, 2023 221.08 Mn
Dec 31, 2022 5.21 Mn
Mar 31, 2022 205.57 Mn
Dec 31, 2021 8.86 Mn
Sep 30, 2021 196.29 Mn
Jun 30, 2021 196.29 Mn
Mar 31, 2021 190.78 Mn
Dec 31, 2020 7.16 Mn